Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06735820
Title Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST (MEKMDM2)
Acronym MEKMDM2
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AeRang Kim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.